BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 76 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 110,447 | $1,346,000 | 1.35% |
| Boxer Capital, LLC | 2,014,858 | $24,561,000 | 0.87% |
| NEA Management Company, LLC | 3,449,845 | $42,054,000 | 0.55% |
| RA Capital Management | 2,589,904 | $31,571,000 | 0.51% |
| Bellevue Group AG | 3,463,000 | $42,214,000 | 0.41% |
| Artal Group S.A. | 1,646,517 | $20,071,000 | 0.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,047,599 | $12,770,000 | 0.23% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 105,396 | $1,285,000 | 0.20% |
| Ikarian Capital, LLC | 153,941 | $1,876,000 | 0.15% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,000 | $535,000 | 0.14% |